Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Motion Sickness: Research Application Comparison

Cerebrolysin Neurotrophic factor delivery (BDNF, NGF, CNTF) Protects vestibular neurons from oxidative stress and age-related degeneration Intramuscular or intravenous injection Refrigerate at 2–8°C; avoid temperature excursions above 25°C Best for neuroprotec

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Cerebrolysin
  • Neurotrophic factor delivery (BDNF, NGF, CNTF)
  • Protects vestibular neurons from oxidative stress and age-related degeneration
  • Intramuscular or intravenous injection
  • Refrigerate at 2–8°C; avoid temperature excursions above 25°C
  • Best for neuroprotection in chronic vestibular dysfunction; not an acute intervention
  • P21
  • CREB pathway activation
  • Enhances synaptic plasticity in brainstem vestibular nuclei, accelerating habituation
  • Intranasal administration
  • Store lyophilized powder at −20°C; reconstituted solution at 2–8°C, use within 28 days
  • Strongest evidence for accelerating vestibular adaptation; requires consistent dosing over days to weeks
  • Dihexa
  • HGF/c-Met pathway modulation
  • Promotes synaptogenesis and neural repair in vestibular pathways
  • Oral or subcutaneous
  • Store lyophilized powder at −20°C; oral bioavailability allows flexible dosing
  • Theoretical application strong; direct vestibular research limited
  • KPV
  • NF-κB inhibition, anti-inflammatory
  • Reduces inner ear and brainstem inflammation that amplifies vestibular mismatch
  • Subcutaneous injection or intranasal
  • Store lyophilized powder at −20°C; reconstituted solution at 2–8°C
  • Most relevant when vestibular symptoms are inflammation-driven; less effective for pure motion mismatch
  • Thymalin
  • Immune modulation, systemic anti-inflammatory
  • Reduces autoimmune inner ear damage and neuroinflammation in vestibular nuclei
  • Subcutaneous injection
  • Targeted to autoimmune vestibular conditions; not applicable to typical motion sickness